Retrospective analysis assesses diagnostic significance of tumor markers in patients with malignant pleural effusions, suggesting limited utility of some markers.
AIM: The diagnostic significance of pleural effusion (PE) tumor markers in malignant pleural effusions (MPEs) was determined. METHODS: A retrospective analysis of 65 cases were pathologically diagnosed with MPEs and 49 cases with tuberculous pleural effusions (TPEs) based on the results of medical thoracoscopic pleural biopsies. The concentrations of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), cancer antigen 125 (CA-125), specific enolase (NSE), and squamous cell carcinoma (SCC) antigen were compared between the two groups. RESULTS: < 0.001). The optimal thresholds for diagnosis of an MPE with a PE CEA and CA 19-9 were 5.80 ng/ml and 12.52 U/ml, respectively, and specificities of 100% and 93.88%, respectively. CONCLUSIONS: The PE CEA and CA 19-9 combination is not superior to CEA alone in diagnosing an MPE. CA-125, NSE, and SCC antigen have no diagnostic value for diagnosing an MPE.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: